Order Total (1 Item Items):
Shipping Destination:
Cavalla David (48 results)
Skip to main search results
Search filters
Product Type
- All Product Types
- Books (48)
- Magazines & Periodicals (No further results match this refinement)
- Comics (No further results match this refinement)
- Sheet Music (No further results match this refinement)
- Art, Prints & Posters (No further results match this refinement)
- Photographs (No further results match this refinement)
- Maps (No further results match this refinement)
- Manuscripts & Paper Collectibles (No further results match this refinement)
Condition Learn more
Binding
Collectible Attributes
Language (2)
Free Shipping
Seller Location
Seller Rating
-
Modern Strategy for Preclinical Pharmaceutical R&D: Towards the Virtual Research Company
Published by John Wiley and Sons,, 1997
Condition: Fair. No Jacket. Ex-library copy with usual marks,clean and tight but for library marks, no dust jacket. INV#J-34.
-
The Chemist in Industry 2: Human Health and Plant Protection
Language: English
Published by Oxford University Press, Oxford, United Kingdom, 1974
ISBN 10: 0198554540 ISBN 13: 9780198554547
Seller: PsychoBabel & Skoob Books, Didcot, United Kingdom
Seller rating 5 out of 5 stars
hardcover. Condition: Very Good. Dust Jacket Condition: Very Good. Clean and unmarked.
-
Off-label Prescribing: Justifying Unapproved Medicine
Seller: WorldofBooks, Goring-By-Sea, WS, United Kingdom
Seller rating 5 out of 5 stars
Paperback. Condition: Very Good. The book has been read, but is in excellent condition. Pages are intact and not marred by notes or highlighting. The spine remains undamaged.
-
Modern Strategy for Preclinical Pharmaceutical R and D.
Seller: Plurabelle Books Ltd, Cambridge, United Kingdom
Association Member: GIAQ
Seller rating 5 out of 5 stars
Signed
Hardback. Condition: As New. x 218p hardback, blue and grey cover, like new condition, little to no wear, binding tight, pages clean and bright like new, author's signature on the front endpaper Language: English.
-
Condition: New.
-
Off-Label Prescribing: Justifying Unapproved Medicine (Hardback or Cased Book)
Language: English
Published by Wiley-Blackwell 3/2/2015, 2015
ISBN 10: 1118912071 ISBN 13: 9781118912072
Hardback or Cased Book. Condition: New. Off-Label Prescribing: Justifying Unapproved Medicine. Book.
-
Condition: As New. Unread book in perfect condition.
-
Off-label Prescribing
Language: English
Published by John Wiley and Sons Ltd, GB, 2015
ISBN 10: 1118912071 ISBN 13: 9781118912072
Seller: Rarewaves.com USA, London, LONDO, United Kingdom
Seller rating 5 out of 5 stars
Hardback. Condition: New. Today's medicines are regulated for their efficacy and safety and, once approved, they can be marketed for certain uses as justified by the data. Regulatory bodies in developed countries are constituted by legal statute and operate as parts of government, ostensibly in the interests of the people as patients. But once approved, medicines can be used for any purpose the prescriber thinks fit and appropriate for the patient. One in five prescriptions is therefore written outside regulatory purview. Off-label Prescribing looks into the corners of our medicated lives, where drug regulation runs up against medical practice, and concerns the use of a drug that has been approved for one use (in medical parlance, 'indication') being used for a different indication; alternatively, being used on a different set of patients from the ones it is approved for, or at a different dose. Usually the patient is unaware of what is going on, having not been informed by their doctor of this aspect of his or her prescribing choice. The book examines how and why this occurs, what the various medical professions have to say about it, and how pharmaceutical companies benefit by moving into this poorly regulated area. Off-label Prescribing pulls these complex issues together in one volume, to highlight current practice, its advantages and weaknesses and how the author suggests practice should evolve in the future. It will therefore be of interest to all those who prescribe (and receive) medicines, combined with a greater objective to provide more transparency and discussion for professionals.
-
hardcover. Condition: Very Good. Off-label Prescribing: Justifying Unapproved Medicine This book is in very good condition and will be shipped within 24 hours of ordering. The cover may have some limited signs of wear but the pages are clean, intact and the spine remains undamaged. This book has clearly been well maintained and looked after thus far. Money back guarantee if you are not satisfied. See all our books here, order more than 1 book and get discounted shipping. .
-
hardcover. Condition: Very Good. Shipped within 24 hours from our UK warehouse. Clean, undamaged book with no damage to pages and minimal wear to the cover. Spine still tight, in very good condition. Remember if you are not happy, you are covered by our 100% money back guarantee.
-
Off-label Prescribing: Justifying Unapproved Medicine
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Seller rating 5 out of 5 stars
£ 42.32
£ 11.98 shipping
Ships from United Kingdom to U.S.A.Quantity: Over 20 available
Add to basketCondition: New. In.
-
Off-label Prescribing : Justifying Unapproved Medicine
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Seller rating 5 out of 5 stars
Condition: New.
-
Off-label Prescribing : Justifying Unapproved Medicine
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Seller rating 5 out of 5 stars
Condition: As New. Unread book in perfect condition.
-
Off-label Prescribing
Language: English
Published by John Wiley and Sons Ltd, GB, 2015
ISBN 10: 1118912071 ISBN 13: 9781118912072
Hardback. Condition: New. Today's medicines are regulated for their efficacy and safety and, once approved, they can be marketed for certain uses as justified by the data. Regulatory bodies in developed countries are constituted by legal statute and operate as parts of government, ostensibly in the interests of the people as patients. But once approved, medicines can be used for any purpose the prescriber thinks fit and appropriate for the patient. One in five prescriptions is therefore written outside regulatory purview. Off-label Prescribing looks into the corners of our medicated lives, where drug regulation runs up against medical practice, and concerns the use of a drug that has been approved for one use (in medical parlance, 'indication') being used for a different indication; alternatively, being used on a different set of patients from the ones it is approved for, or at a different dose. Usually the patient is unaware of what is going on, having not been informed by their doctor of this aspect of his or her prescribing choice. The book examines how and why this occurs, what the various medical professions have to say about it, and how pharmaceutical companies benefit by moving into this poorly regulated area. Off-label Prescribing pulls these complex issues together in one volume, to highlight current practice, its advantages and weaknesses and how the author suggests practice should evolve in the future. It will therefore be of interest to all those who prescribe (and receive) medicines, combined with a greater objective to provide more transparency and discussion for professionals.
-
Off-label Prescribing
Language: English
Published by John Wiley & Sons Mär 2015, 2015
ISBN 10: 1118912071 ISBN 13: 9781118912072
Buch. Condition: Neu. Neuware - Today's medicines are regulated for their efficacy and safety and, once approved, they can be marketed for certain uses as justified by the data. Regulatory bodies in developed countries are constituted by legal statute and operate as parts of government, ostensibly in the interests of the people as patients.But once approved, medicines can be used for any purpose the prescriber thinks fit and appropriate for the patient. One in five prescriptions is therefore written outside regulatory purview.Off-label Prescribing looks into the corners of our medicated lives, where drug regulation runs up against medical practice, and concerns the use of a drug that has been approved for one use (in medical parlance, 'indication') being used for a different indication; alternatively, being used on a different set of patients from the ones it is approved for, or at a different dose. Usually the patient is unaware of what is going on, having not been informed by their doctor of this aspect of his or her prescribing choice.The book examines how and why this occurs, what the various medical professions have to say about it, and how pharmaceutical companies benefit by moving into this poorly regulated area. Off-label Prescribing pulls these complex issues together in one volume, to highlight current practice, its advantages and weaknesses and how the author suggests practice should evolve in the future. It will therefore be of interest to all those who prescribe (and receive) medicines, combined with a greater objective to provide more transparency and discussion for professionals.
-
Drug Repurposing
Language: English
Published by Royal Society of Chemistry, 2022
ISBN 10: 1788019032 ISBN 13: 9781788019033
Condition: New.
-
Drug Repurposing
Language: English
Published by Royal Society of Chemistry, GB, 2022
ISBN 10: 1788019032 ISBN 13: 9781788019033
Hardback. Condition: New. Drug repurposing is the development of existing drugs for new uses: given that 9 in 10 drugs that enter drug development are never marketed and therefore represent wasted effort, it is an attractive as well as inherently more efficient process. Three repurposed drugs can be brought to market for the same cost as one new chemical entity; and they can also be identified more quickly, an important benefit for patients whose diseases are progressing faster than therapeutic innovation. But repurposing also requires a fresh look at configuring pharmaceutical RandD, considering clinical, regulatory and patent issues much earlier than would otherwise be the case; a holistic gedanken experiment almost needs to be undertaken at the very start of any repurposing development. In addition to new ways of thinking, the discovery of repurposing opportunities can take advantage of artificial intelligence techniques to match the perfect new use for an existing drug. And while repurposing of medicines has been in the mind of every doctor since Hypocrates, modern clinical practice will simply have to adapt to new repurposing techniques in an age where the number of known diseases is increasing much faster than the healthcare dollars available.
-
Drug Repurposing
Seller: PBShop.store UK, Fairford, GLOS, United Kingdom
Seller rating 5 out of 5 stars
HRD. Condition: New. New Book. Shipped from UK. Established seller since 2000.
-
HRD. Condition: New. New Book. Shipped from UK. Established seller since 2000.
-
Drug Repurposing
Language: English
Published by Royal Society of Chemistry, 2022
ISBN 10: 1788019032 ISBN 13: 9781788019033
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Seller rating 5 out of 5 stars
£ 179.37
£ 15 shipping
Ships from United Kingdom to U.S.A.Quantity: Over 20 available
Add to basketCondition: New.
-
Drug Repurposing
Language: English
Published by Royal Society of Chemistry, 2022
ISBN 10: 1788019032 ISBN 13: 9781788019033
Condition: As New. Unread book in perfect condition.
-
Modern Strategy for Preclinical Pharmaceutical RandD
Seller: PBShop.store UK, Fairford, GLOS, United Kingdom
Seller rating 5 out of 5 stars
HRD. Condition: New. New Book. Shipped from UK. Established seller since 2000.
-
-
Drug Repurposing (Drug Discovery Series, Volume 82)
Language: English
Published by Royal Society of Chemistry, 2022
ISBN 10: 1788019032 ISBN 13: 9781788019033
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Seller rating 5 out of 5 stars
£ 199.42
£ 11.98 shipping
Ships from United Kingdom to U.S.A.Quantity: Over 20 available
Add to basketCondition: New. In.
-
-
Drug Repurposing
Language: English
Published by Royal Society of Chemistry, 2022
ISBN 10: 1788019032 ISBN 13: 9781788019033
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Seller rating 5 out of 5 stars
£ 198.18
£ 15 shipping
Ships from United Kingdom to U.S.A.Quantity: Over 20 available
Add to basketCondition: As New. Unread book in perfect condition.
-
Modern Strategy for Preclinical Pharmaceutical R & D : Towards the Virtual Research Company
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Seller rating 5 out of 5 stars
£ 201.31
£ 15 shipping
Ships from United Kingdom to U.S.A.Quantity: Over 20 available
Add to basketCondition: New.
-
Drug Repurposing
Language: English
Published by Royal Society of Chemistry, GB, 2022
ISBN 10: 1788019032 ISBN 13: 9781788019033
Hardback. Condition: New. Drug repurposing is the development of existing drugs for new uses: given that 9 in 10 drugs that enter drug development are never marketed and therefore represent wasted effort, it is an attractive as well as inherently more efficient process. Three repurposed drugs can be brought to market for the same cost as one new chemical entity; and they can also be identified more quickly, an important benefit for patients whose diseases are progressing faster than therapeutic innovation. But repurposing also requires a fresh look at configuring pharmaceutical RandD, considering clinical, regulatory and patent issues much earlier than would otherwise be the case; a holistic gedanken experiment almost needs to be undertaken at the very start of any repurposing development. In addition to new ways of thinking, the discovery of repurposing opportunities can take advantage of artificial intelligence techniques to match the perfect new use for an existing drug. And while repurposing of medicines has been in the mind of every doctor since Hypocrates, modern clinical practice will simply have to adapt to new repurposing techniques in an age where the number of known diseases is increasing much faster than the healthcare dollars available.
-
Modern Strategy for Preclinical Pharmaceutical R&D: Towards the Virtual Research Company
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Seller rating 5 out of 5 stars
£ 206.29
£ 11.98 shipping
Ships from United Kingdom to U.S.A.Quantity: Over 20 available
Add to basketCondition: New. In.
-
Condition: As New. Unread book in perfect condition.
